Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression

Journal of Nutritional Biochemistry

Volumn 22, Issue 4, 2011, Pages 351-359

  Lee, Yuan Wen ^a   Lin, Jui An ^a   Chang, Chuen Chau ^a   Chen, Yung Hsiang ^b   Liu, Po Len ^c   Lee, Ai Wei ^a   Tsai, Jui Chi ^d   Li, Chi Yuan ^b   Tsai, Chien Sung ^d   Chen, Ta Liang ^a   Lin, Feng Yen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Ginkgo biloba extract; Nitric oxide; Toll like receptor 4; Tristetraprolin

Indexed keywords

DACTINOMYCIN; ENDOTOXIN; GINKGO BILOBA EXTRACT; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 4; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ARTICLE; CELL ACTIVATION; CELL LINE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; GENETIC TRANSFECTION; GINKGO BILOBA; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; IMMUNOPRECIPITATION; MONOCYTE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BLOCKING; RNA STABILITY; WESTERN BLOTTING;

CELL LINE; DACTINOMYCIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GINKGO BILOBA; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; NITRIC OXIDE; PLANT EXTRACTS; S-NITROSO-N-ACETYLPENICILLAMINE; TOLL-LIKE RECEPTOR 4; TRISTETRAPROLIN;

GINKGO BILOBA;

EID: 79952535187     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.03.002     Document Type: Article

References (50)

1. Muzio M., Mantovani A. Toll-like receptors. Microbes Infect 2000, 2:251-255.
2. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
3. Means T.K., Golenbock D.T., Fenton M.J. The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000, 11:219-232.
4. O'Neill L.A., Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 1998, 63:650-657.
5. Carpenter S., O'Neill L.A. How important are Toll-like receptors for antimicrobial responses?. Cell Microbiol 2007, 9:1891-1901.
6. Shoham S., Huang C., Chen J.M., Golenbock D.T., Levitz S.M. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol 2001, 166:4620-4626.
7. Netea M.G., Van der Graaf C., Van der Meer J.W., Kullberg B.J. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 2004, 23:672-676.
8. Vabulas R.M., Wagner H., Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 2002, 270:169-184.
9. Liu B., Dai J., Zheng H., Stoilova D., Sun S., Li Z. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A 2003, 100:15824-15829.
10. Park J.S., Svetkauskaite D., He Q., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004, 279:7370-7377.
11. Termeer C., Benedix F., Sleeman J., et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
12. Miller Y.I., Viriyakosol S., Binder C.J., Feramisco J.R., Kirkland T.N., Witztum J.L. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 2003, 278:1561-1568.
13. Johnson G.B., Brunn G.J., Platt J.L. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 2004, 172:20-24.
14. Li M., Zhou Y., Feng G., Su S.B. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 2009, 9:365-374.
15. Tsan M.F., Clark R.N., Goyert S.M., White J.E. Induction of TNF-alpha and MnSOD by endotoxin: role of membrane CD14 and Toll-like receptor-4. Am J Physiol Cell Physiol 2001, 280:C1422-C1430.
16. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
17. Karlsson H., Larsson P., Wold A.E., Rudin A. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect Immun 2004, 72:2671-2678.
18. Shiraki R., Inoue N., Kobayashi S., et al. Toll-like receptor 4 expressions on peripheral blood monocytes were enhanced in coronary artery disease even in patients with low C-reactive protein. Life Sci 2006, 80:59-66.
19. Satoh M., Shimoda Y., Maesawa C., et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006, 109:226-234.
20. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003, 85:85-95.
21. Kleijnen J., Knipschild P. Ginkgo biloba. Lancet 1992, 340:1136-1139.
22. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F.A. placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAmA 1997, 278:1327-1332.
23. Varga E., Bodi A., Ferdinandy P., Droy-Lefaix M.T., Blasig I.E., Tosaki A. The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol 1999, 34:711-717.
24. Akiba S., Kawauchi T., Oka T., Hashizume T., Sato T. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int 1998, 46:1243-1248.
25. Marcocci L., Maguire J.J., Droy-Lefaix M.T., Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 1994, 201:748-755.
26. Yan L.J., Droy-Lefaix M.T., Packer L. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Commun 1995, 212:360-366.
27. Shen J.G., Zhou D.Y. Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury. Biochem Mol Biol Int 1995, 35:125-134.
28. Szabo M.E., Droy-Lefaix M.T., Doly M. Modification of reperfusion-induced ionic imbalance by free radical scavengers in spontaneously hypertensive rat retina. Free Radic Biol Med 1992, 13:609-620.
29. Lin F.Y., Chen Y.H., Lin Y.W., et al. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol 2006, 26:2622-2629.
30. Lin F.Y., Chen Y.H., Tasi J.S., et al. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 2006, 26:2630-2637.
31. Lin F.Y., Chen Y.H., Chen Y.L., et al. Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation. J Agric Food Chem 2007, 55:1977-1984.
32. Chen Y.H., Lin S.J., Lin F.Y., et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007, 56:1559-1568.
33. Zhang X.Y., Zhou D.F., Cao L.Y., Wu G.Y. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2006, 188:12-17.
34. Villasenor-Garcia M.M., Lozoya X., Osuna-Torres L., Viveros-Paredes J.M., Sandoval-Ramirez L., Puebla-Perez A.M. Effect of Ginkgo biloba extract EGb 761 on the nonspecific and humoral immune responses in a hypothalamic-pituitary-adrenal axis activation model. Int Immunopharmacol 2004, 4:1217-1222.
35. Ho L.J., Lai J.H. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr Drug Metab 2004, 5:181-192.
36. Sharma B.K., Kumar K. Role of proinflammatory cytokines in cerebral ischemia: a review. Metab Brain Dis 1998, 13:1-8.
37. Watkins L.R., Nguyen K.T., Lee J.E., Maier S.F. Dynamic regulation of proinflammatory cytokines. Adv Exp Med Biol 1999, 461:153-178.
38. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
39. Jiao Y.B., Rui Y.C., Yang P.Y., Li T.J., Qiu Y. Effects of Ginkgo biloba extract on expressions of IL-1beta, TNF-alpha, and IL-10 in U937 foam cells. Yao Xue Xue Bao 2007, 42:930-934.
40. Jiao Y.B., Rui Y.C., Li T.J., Yang P.Y., Qiu Y. Expression of pro-inflammatory and anti-inflammatory cytokines in brain of atherosclerotic rats and effects of Ginkgo biloba extract. Acta Pharmacol Sin 2005, 26:835-839.
41. Marletta M.A. Nitric oxide synthase structure and mechanism. J Biol Chem 1993, 268:12231-12234.
42. Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function. Circ Res 1996, 79:363-380.
43. Juliet P.A., Hayashi T., Iguchi A., Ignarro L.J. Concomitant production of nitric oxide and superoxide in human macrophages. Biochem Biophys Res Commun 2003, 310:367-370.
44. Brown G.C. Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 1995, 232:188-191.
45. Asahi M., Fujii J., Suzuki K., et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem 1995, 270:21035-21039.
46. Barker J.E., Heales S.J., Cassidy A., Bolanos J.P., Land J.M., Clark J.B. Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res 1996, 716:118-122.
47. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994, 269:29405-29408.
48. Ilieva I., Ohgami K., Shiratori K., et al. The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res 2004, 79:181-187.
49. Wadsworth T.L., Koop D.R. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem Biol Interact 2001, 137:43-58.
50. Park Y.M., Won J.H., Yun K.J., et al. Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-kappaB in RAW 264.7 cells. Biol Pharm Bull 2006, 29:985-990.